Purchases and Sales Made in Q3 2022 in Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL) during Q3 2022. The information is specifically focused on institutions that hold shares of Zentalis Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-65.6K- 82.9% |
$1.33M - $2.08M
|
13.5K
$30.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-70.1K- 25.07% |
$1.42M - $2.22M
|
209K
$469K
|
|
|
Nov 08, 2022
Q3 2022
|
New York State Common Retirement Fund
|
SELL
|
- |
-85.6K- 71.78% |
$1.73M - $2.71M
|
33.6K
$75.4K
|
|
|
Nov 14, 2022
Q3 2022
|
Tybourne Capital Management (Hk) LTD
Hong Kong, K3 |
SELL
|
- |
-124K- 5.12% |
$2.52M - $3.94M
|
2.3M
$5.16M
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-187K- 60.53% |
$3.79M - $5.94M
|
122K
$274K
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-210K- 27.52% |
$4.25M - $6.66M
|
553K
$1.24M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-248K- 71.83% |
$5.02M - $7.88M
|
97.4K
$218K
|
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-270K- 8.64% |
$5.45M - $8.55M
|
2.85M
$6.38M
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-386K- 8.59% |
$7.81M - $12.3M
|
4.11M
$9.2M
|
|
|
Nov 14, 2022
Q3 2022
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-572K- 60.25% |
$11.6M - $18.2M
|
378K
$846K
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-2.08M- 48.41% |
$42.1M - $66M
|
2.22M
$4.97M
|